Clinical Trials Logo
  1. Home
  2. Juvenile Idiopathic Arthritis
  3. NCT04167488
  4. Details
NCT04167488 Clinical Trial

Assessment of Physical Activity Among Juvenile Idiopathic Arthritis Children Performed With Actigraphy

Juvenile Idiopathic Arthritis Clinical Trial

— AJIACT  

Official title:
Assessment of Physical Activity Among Juvenile Idiopathic Arthritis Children Performed With Actigraphy

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04167488
Other study ID # P/2019/432
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 10, 2019
Est. completion date December 2019

Study information
Verified date November 2019
Source Centre Hospitalier Universitaire de Besancon
Contact Laure JONYK, Int
Phone 0033381218135
Email laure.jonyk@orange.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to describe physical activity among juvenile idiopathic arthritis children, according to the disease's and patient's characteristics.

Recruitment information / eligibility
Status Recruiting
Enrollment 50
Est. completion date December 2019
Est. primary completion date December 2019
Accepts healthy volunteers No
Gender All
Age group 4 Years to 18 Years
Eligibility Inclusion Criteria:

- Juvenile idiopathic arthritis evolving for more than a year

Exclusion Criteria:

- intra-articular infiltration performed less than a month ago

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Actigraphic measurement
Physical activity assessed with actigraphic device worn during 7 days

Locations
Country Name City State
France CHU de Besançon Besançon

Sponsors (1)
Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Besancon

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Physical activity assessment Physical activity will be measured with actigraphic device and children will be divided into 3 groups of activity levels: low / moderate / high.
Low is < or = 1000 counts per minute Moderate is > 1000 counts per minute High is > 2500 per minute		 Day 7
See also
  Status Clinical Trial Phase
Completed NCT02776735 - An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) Phase 2
Active, not recruiting NCT03092427 - Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA) N/A
Not yet recruiting NCT05545098 - MSUS Versus Serum Survivin and Lubricin Levels in Evaluation of Disease Activity in JIA
Not yet recruiting NCT03833609 - Yoga and Aerobic Dance for Pain Management in Juvenile Idiopathic Arthritis N/A
Completed NCT02524340 - Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
Recruiting NCT01434082 - Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis N/A
Completed NCT04671524 - The Effect of Improvement in Function on Foot Pressure, Balance and Gait in Children With Upper Extremity Affected N/A
Recruiting NCT04205500 - Treatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis N/A
Terminated NCT01694264 - Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα Phase 3
Completed NCT02824978 - Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ?
Active, not recruiting NCT03841357 - Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA) Phase 3
Completed NCT03833271 - The Efficacy of Influenza Vaccine Program in Children With Juvenile Idiopathic Arthritis. A Single Centre Results From Hungary Early Phase 1
Completed NCT01455701 - A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) Phase 1
Completed NCT05031104 - Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis N/A
Not yet recruiting NCT01436019 - Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis N/A
Recruiting NCT05609630 - Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis. Phase 3
Recruiting NCT05696340 - Access to Pediatric Rheumatology Centers for JIA Patients: Factors Associated With Time to Access Pediatric Rheumatology Centers
Recruiting NCT05545839 - Transition to Adulthood Through Coaching and Empowerment in Rheumatology N/A
Completed NCT05436301 - Turkish Validity and Reliability of Pain Catastrophizing Scale-Child (PCS-C)
Not yet recruiting NCT05467579 - Mandibular Advancement Clear Aligner Treatment in Juvenile Idiopathic Arthritis Subjects N/A